Dentsply Sirona (XRAY) Tops Q2 EPS by 17c ; Offers Guidance

Dentsply Sirona (NASDAQ: XRAY) reported Q2 EPS of $0.52, $0.17 better than the analyst estimate of $0.35. Revenue for the quarter came in at $898 million versus the consensus estimate of $889.15 million.

FY 2026 Outlook:-

Net sales in the range of $3.5 billion to $3.6 billion vs consensus $3.58 billion.
EPS in the range of $1.40 to $1.50 vs consensus $1.42.

For earnings history and earnings-related data on Dentsply Sirona (XRAY) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c
• Epsilon Energy Ltd. (EPSN) Reports Q2 EPS of $0.23